Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy

This post hoc analysis assessed clinical and functional responses to tofacitinib monotherapy, tofacitinib  + methotrexate (MTX), and adalimumab + MTX, in patients with rheumatoid arthritis enrolled in the ORAL ...

Source: Arthritis Research and Therapy - August 24, 2021 Category: Rheumatology Authors: Tsutomu Takeuchi, Roy Fleischmann, Noriko Iikuni, Harry Shi, Koshika Soma, Jerome Paulissen, Tomohiro Hirose and Josef S. Smolen Tags: Research article Source Type: research